No Artificial Flavor or Sweetener, No Sugar, No Starch, No Milk, No Lactose, No Soy, No Gluten, No Wheat, No Yeast, No Fish
Medical experts highlight that GLP-1 therapy should be seen as part of a broader health system rather than a quick intervention
In the SUSTAIN 6 trial, participants receiving Ozempic experienced an average weight loss of 4.5 kg (9.9 lbs) after 104 weeks, compared to 0.5 kg (1.1 lbs) in the placebo group[4]
Days 2-4: The Adjustment Phase What to expect: This is when most side effects appear
in 2024, which synthesized data across seven randomized controlled trials (RCTs) reporting on BMD and BTMs in participants (average age: 51.7 years) allocated to either GLP1Ra or placebo/control for an average of 33.7 weeks
2-OH is the least associated with DNA damage that causes cancer and has the weakest estrogenic effect